About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
JACC: Heart Failure
›
Top Articles
JACC: Heart Failure
7.9
(top 1%)
Impact Factor
8.9
(top 1%)
extended IF
82
(top 5%)
H-Index
757
authors
1K
papers
28.6K
citations
2.2K
citing journals
17.1K
citing authors
Most Cited Articles of JACC: Heart Failure
Title
Year
Citations
Heart failure
2013
481
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure
2013
323
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure
2013
265
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
2016
262
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial
2014
242
Developing therapies for heart failure with preserved ejection fraction: current state and future directions
2014
213
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction
2014
212
Risk prediction in patients with heart failure: a systematic review and analysis
2014
209
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
2015
190
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial
2017
176
Pathogenic Gut Flora in Patients With Chronic Heart Failure
2016
166
Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure
2013
165
Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device
2014
164
The Transition From Hypertension to Heart Failure: Contemporary Update
2017
160
Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure
2014
158
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
2017
148
Cardiopulmonary Exercise Testing in Heart Failure
2016
147
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis
2017
143
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study
2017
139
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction
2015
139
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
2018
138
The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients
2013
134
Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction
2016
133
HVAD: The ENDURANCE Supplemental Trial
2018
129
Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure
2014
129
previous
2016
2017
2018
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.